NEW YORK – A new method of determining point mutations associated with infectious disease drug resistance could provide a path to cheap diagnostics for low-resource regions.
In a study published in Cell last month, a team led by researchers at the Biodesign Center for Molecular Design and Biomimetics at the Biodesign Institute at Arizona State University developed programmable riboregulators (SNIPRs) as a method to detect single-nucleotide mutations in genes.